Accelerate Diagnostics Inc expected to post a loss of 62 cents a share - Earnings Preview

Accelerate Diagnostics

26/03/2024 20:11

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 28 for the period ending December 31 2023
    * The Denver Colorado-based  company is expected to report a
15.9% increase in revenue to $3.446 million from $2.97 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Accelerate Diagnostics
Inc is
for a loss of 62 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $2.00​, above​ its last closing price
of $1.00. ​​​

This summary was machine generated March 26 at 20:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)